The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
基本信息
- 批准号:10607301
- 负责人:
- 金额:$ 66.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary - The role of liver progenitor cells in liver regeneration
Acute and chronic liver disease causes liver failure and is a growing cause for morbidity and
mortality. The COVID-19 pandemic has further increased the magnitude of this problem. The liver
is a highly regenerative organ, yet the presence of a dedicated stem cell population remains
controversial. In our preliminary work, we describe a near-total hepatocyte ablation model in
zebrafish where organ regeneration is derived from biliary epithelial cells. Our objective here is to
characterize the functional implications and molecular mechanisms of EAE to affect organ
development. Our central hypothesis is that severe hepatocyte injury will reveal the facultative
stem cell potential of biliary epithelial cells. This process appears to be driven by EGFR, PI3K,
and mTOR signaling. Two Specific Aims are proposed to define the generation and contribution
of facultative hepatic stem cells. In Specific Aim 1 we will utilize single-cell transcriptomic and
high-resolution imaging analyses after near-total hepatocyte ablation to investigate whether and
when biliary epithelial cells undergo transcriptional and morphological changes to become
hepatocytes. In the process, we will generate an inventory of all liver cells in the zebrafish and
determine evolutionary conservation of cell identity and function by comparison to murine and
human liver datasets. Specific Aim2 will determine the degree of biliary epithelial cell proliferation
hepatoblast transcription factors gene expression prior to hepatocyte differentiation and define
the signaling pathways involved in the generation, function and proliferation of this facultative
stem cell population. Identification of a signal like EGFR that can cause biliary epithelial cells to
become hepatocytes has significant therapeutic potential for patients with liver failure.
项目摘要 - 肝祖细胞在肝脏再生中的作用
急性和慢性肝病会导致肝衰竭,并且是发病率和
死亡。 COVID-19大流行进一步增加了该问题的幅度。肝脏
是高度再生器官,但仍存在专用的干细胞种群
有争议的。在我们的初步工作中,我们描述了一种近乎全部的肝细胞消融模型
斑马鱼,其中器官再生源自胆道上皮细胞。我们的目标是
表征EAE的功能含义和分子机制影响器官
发展。我们的中心假设是严重的肝细胞损伤将揭示兼职
胆道上皮细胞的干细胞电位。此过程似乎是由EGFR驱动的,PI3K,
和mTOR信号传导。提出了两个具体目标来定义生成和贡献
辅助肝干细胞。在特定目标1中,我们将使用单细胞转录组和
几乎全肝细胞消融后进行高分辨率成像分析,以研究是否和
当胆道上皮细胞经历转录和形态学变化
肝细胞。在此过程中,我们将生成斑马鱼中所有肝细胞的清单
通过与鼠相比,确定细胞身份和功能的进化保护
人肝数据集。特定的AIM2将确定胆道上皮细胞增殖的程度
肝细胞分化之前的肝类母细胞转录因子基因表达并定义
该夫妇的发电,功能和增殖涉及的信号传导途径
干细胞种群。识别像EGFR这样的信号,该信号可能导致胆汁上皮细胞
成为肝细胞对于肝衰竭患者具有显着的治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Wolfram Goessling的其他基金
The Role of Macrophages in Hepatobiliary Development
巨噬细胞在肝胆发育中的作用
- 批准号:1068084610680846
- 财政年份:2023
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
A community resource for germline and somatic genetic disease modeling in zebrafish
斑马鱼种系和体细胞遗传疾病模型的社区资源
- 批准号:1072315810723158
- 财政年份:2023
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Metabolic Regulation of Liver Growth
肝脏生长的代谢调节
- 批准号:99751409975140
- 财政年份:2016
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Metabolic Regulation of Liver Growth
肝脏生长的代谢调节
- 批准号:97653009765300
- 财政年份:2016
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Metabolic Regulation of Liver Growth
肝脏生长的代谢调节
- 批准号:93158039315803
- 财政年份:2016
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
A Community Zebrafish Resource for Modeling GWAS Biology
用于 GWAS 生物学建模的社区斑马鱼资源
- 批准号:88403368840336
- 财政年份:2014
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
A Community Zebrafish Resource for Modeling GWAS Biology
用于 GWAS 生物学建模的社区斑马鱼资源
- 批准号:86091338609133
- 财政年份:2014
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
A Community Zebrafish Resource for Modeling GWAS Biology
用于 GWAS 生物学建模的社区斑马鱼资源
- 批准号:97636799763679
- 财政年份:2014
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
A Community Zebrafish Resource for Modeling GWAS Biology
用于 GWAS 生物学建模的社区斑马鱼资源
- 批准号:1022556610225566
- 财政年份:2014
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Estrogen Regulation of Hepatic Growth
雌激素对肝脏生长的调节
- 批准号:88508498850849
- 财政年份:2011
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
相似国自然基金
CHAC1通过调控蛋白谷胱甘肽化修饰促进对乙酰氨基酚诱导急性药物性肝损伤的作用和机制研究
- 批准号:82370597
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶TRIM25通过调控肝脏枯否细胞天然免疫反应影响对乙酰氨基酚诱导急性药物性肝损伤结局的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
泛素连接酶TRIM25通过调控肝脏枯否细胞天然免疫反应影响对乙酰氨基酚诱导急性药物性肝损伤结局的机制研究
- 批准号:82270619
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
OPTN调控对乙酰氨基酚急性肝损伤的分子机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
共刺激分子OX40通过调控CD4+T 细胞活化加重对乙酰氨基酚急性肝损伤的机制研究
- 批准号:81900526
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury
先天模式识别受体和对乙酰氨基酚诱导的肝损伤
- 批准号:1026533110265331
- 财政年份:2019
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury
先天模式识别受体和对乙酰氨基酚诱导的肝损伤
- 批准号:1061239010612390
- 财政年份:2019
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury
先天模式识别受体和对乙酰氨基酚诱导的肝损伤
- 批准号:95582689558268
- 财政年份:2019
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Innate Pattern Recognition Receptor and Acetaminophen-induced Liver Injury
先天模式识别受体和对乙酰氨基酚诱导的肝损伤
- 批准号:1042722210427222
- 财政年份:2019
- 资助金额:$ 66.91万$ 66.91万
- 项目类别:
Role of microRNA_21 in acetaminophen-induced acute liver failure
microRNA_21在对乙酰氨基酚诱导的急性肝衰竭中的作用
- 批准号:94336459433645
- 财政年份:2017
- 资助金额:$ 66.91万$ 66.91万
- 项目类别: